The incidence of hepatitis B infection in Australia: An epidemiological review

Medical Journal of Australia

Volumn 165, Issue 6, 1996, Pages 322-326

  Kaldor, John M ^a,b   Plant, Aileen J ^a,c,d   Thompson, Sandy C ^a,e   Longbottom, Helen ^a,f   Rowbottom, Jill ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b The Australian National University   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d FAIRFIELD HOSPITAL   (Australia)

^e Fisheries and Forestry   (Australia)

^f Grace Vaughan House   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; FEMALE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; VERTICAL TRANSMISSION;

EID: 0029798670     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1996.tb124993.x     Document Type: Article

References (42)

1. Hardy GL. Epidemiology and genetics of hepatitis among Australian Aborigines [MSc thesis]. Newcastle: University ot Newcastle, 1982.
2. Gilbert GL. Prevention of vertical transmission of hepatitis B. The place of routine screening in antenatal care, and the case for immunisation of infants at risk. Med J Aust 1984; 141: 213-216.
3. Boughton C, Hawkes R. Viral hepatitis and the drug cult: a brief socioepidemiological study in Sydney. Aust N Z J Med 1980; 10: 157-161.
4. Richards M, Lucas CR, Gust I. Hepatitis in male homosexuals in Melbourne [letter]. Med J Aust 1983; 2: 474-475.
5. Burrell CJ, Cameron AS, Hart G, et al. Hepatitis B reservoir and attack rates in an Australian community. Med J Aust 1983; 2: 492-496.
6. Christopher PJ, Mailer PT, Crewe EB, Murphy AM. Hepatitis B infection among STD clinic patients in Sydney. Aust N Z J Med 1984; 14: 491-494.
7. Kane M, Global programme for control of hepatitis B infection. Vaccine 1995; 13 (Suppl 1):S47-S49.
8. Thomas IL. Cost effectiveness of antenatal hepatitis B screening and vaccination of infants. Aust J Obstet Gynaecol 1990; 30: 331-335.
9. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975;292: 771-774.
10. Okada K, Kamiyama I, Inomata M, et al. e-Antigen and anti-e in the serum of asymptomatic carriers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976; 294: 746-749.
11. Szmuness W, Much MI, Prince AM. On the role of sexual behaviour in the spread of hepatitis B infection. Ann intern Med 1975; 83: 489-495.
12. Thomas IL, Wright G. Should all pregnant women be screened for hepatitis B surface antigen? [letter]. Med J Aust 1989; 150: 346-347.
13. Wong VC, Ip HmH, Reesink HW, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis B vaccine and hepatitis B immunoglobulin. Double blind randomised placebo-controlled study. Lancet 1984; 1: 921-926.
14. Australian Bureau of Statistics. Australian Demographic Statistics June quarter 1994, Canberra: ABS, 1994. (Catalogue No. 3101.0.)
15. Wan X, Currie B, Miller N, Mathews JD. Acute hepatitis B infection in Aboriginal Australians. Aust J Public Health 1993; 17: 4: 331-333.
16. Britton WJ, Cossart Y, Parsons C, et al. Risk factors associated with hepatitis B infection in antenatal patients. Aust N Z J Med 1985; 16: 642-644.
17. Thye HM, deCosta C. Screening for hepatitis B in antenatal patients. Med J Aust 1987; 147: 202.
18. Moore DJ, Bucens MR, Holman CDJ, et al. Prenatal screening for markers of hepatitis B in Aboriginal mothers resident in non-metropolitan Western Australia. Med J Aust 1987; 147: 557-558.
19. Pesce AF, Crew EB, Cunningham AL. Should all pregnant women be screened for hepatitis B surface antigen? Med J Aust 1989; 150: 19-21.
20. Commonwealth Department of Community Services and Health National AIDS Campaign. Benchmark Survey 1986-87 Summary Report 1: General Population and Adolescents 1988. Canberra: The Department.
21. Ross MW. Prevalence of risk factors for human immunodeficiency virus infection in the Australian population. Med J Aust 1988; 149: 362-365.
22. Davis LG, Weber DJ, Lemon SM. Horizontal transmission of hepatitis B virus. Lancet 1989; 1: 889-893.
23. Burgess MA, McIntosh DG, Allars HM, Kendrick KG. Hepatitis B in urban Australian school children. No evidence of horizontal transmission between high-risk and low-risk groups. Med J Aust 1993; 159: 315-319.
24. Milne A, Allwood G, Moyes CD, et al. A seroepidemiological study of the prevalence of hepatitis B infection in a hyperendemic New Zealand community. Int J Epidemiol 1987; 16: 84-90.
25. Gardner ID, Wan X, Simms PA, et al. Hepatitis B virus markers in children and staff in Northern Territory schools. Med J Aust 1992; 156: 638-641.
26. Gill JS, Bucens M, Hatton W, et al. Markers of hepatitis B infection in school children in the Kimberley, Western Australia. Med J Aust 1990; 153: 34-37.
27. Campbell DH, Plant AJ, Sargent JW, et al. Hepatitis B infection of children in a mixed-race community in western New South Wales. Med J Aust 1991; 154: 253-256.
28. Campbell DH, Sargent JW, Plant AJ. The prevalence of markers of infection with hepatitis B virus in a mixed race Australian community. Med J Aust 1989; 150: 489-492.
29. Beasley RP, Hwang L-Y, Lin C-C, et al. Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis 1982; 146: 2: 198-204.
30. Milne A, Allwood GK, Moyes CD, et al. A seroepidemiological study of the prevalence of hepatitis B infections in a hyperendemic New Zealand community. Int J Epidemiol 1987; 16: 84-90.
31. AIDS/STD Unit. Department of Health and Community Services, Victoria. Surveillance of sexually transmissible diseases in Victoria 1991, 1992, 1993 and 1994. Melbourne: The Department, 1992-1995.
32. Anderson B, Bodsworth N, Rorschiem R, et al. Hepatitis B infection and vaccination status of high risk people in Sydney: 1982 and 1991. Med J Aust 1994; 161: 368-371.
33. Crofts N, Hopper JL, Milner R, et al. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV. Eur J Epidemiol 1996. In press.
34. Alter MJ, Mares A, Hadler SC, et al. The effect of under-reporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol 1987; 125: 133-139.
35. Crofts N, Stewart T, Hearne P, et al. Spread of bloodborne viruses among Australian prison entrants. BMJ 1995; 310: 285-288.
36. Rushworth RL, Bell SM, Rob MI, Taylor PT. Diagnostic testing during pregnancy: a descriptive analysis of utilisation data. Aust J Public Health 1994; 18: 401-406.
37. National Health and Medical Research Council. Antenatal Care. Report of the 106th session of the Council, Canberra, November 1988. Canberra: NHMRC.
38. National Health and Medical Research Council. Recommendations on hepatitis B immunisation. A report by the NHMRC Hepatitis B Working Party, June 1996. Canberra: AGPS. In press.
39. ResnicK RB. A hepatitis B vaccination programme for inner metropolitan Sydney neonates. Med J Aust 1991; 155: 153-156.
40. Jayaram S. Neonatal hepatitis B vaccination program. NSW Public Health Bull 1992; 3: 27-28.
41. Riley R, Maher C, Kolbe A. Hepatitis B vaccination of high-risk neonates in the south west region of New South Wales: evaluation of program coverage. Aust J Public Health 1993; 17: 171-173.
42. White CM, Lincs DR. Compliance with neonatal hepatitis B vaccination [letter]. Med J Aust 1995; 162: 613.